Acta Med. 2006, 49: 51-57
https://doi.org/10.14712/18059694.2017.110
Course and Prognosis of Sarcoidosis in a Referral Setting in Turkey; Analysis of 166 Patients
References
1. ACCESS Research Group. Design of a case controlled etiologic study of sarcoidosis. (ACCES). J Clin Epidemiol 1999; 52:1173–86.
2. American Thoracic Society, European Respiratory Society, World Association of Sarcoidosis and Other Granulamatous Diseases. Statement on sarcoidosis. Am J Respir Crit Care Med 1999;160:736–55.
3. Am J Respir Crit Care Med 2001; 164:1885–9.
< RP, Teirstein AT, Judson MA et al. Clinical charecteristics of patients in a case control study of sarcoidosis (ACCESS). https://doi.org/10.1164/ajrccm.164.10.2104046>
4. AM J Respir Crit Care Med 1997; 156:1601–5.
M, Fogdell HA, Olerup O et al. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis.
5. Thorax 1984; 39:14–8.
< NJ, Crean P, Long JP, Fitzgerald MX. High prevalance of familial sarcoidosis in an Irish population. https://doi.org/10.1136/thx.39.1.14>
<PubMed>
6. Epidemiol Rev 1983; 5:124–56.
EA, Strom BL. Epidemiology of sarcoidosis.
7. Sarcoidosi Vasc Diffuse Lung Dis 2000; 17:167–73.
Ag, Cheung W, Hutchings HA. Sarcoidosis: a long term follow up study.
8. Crystal RG. Sarcoidosis. In: Fauci AS, Braunwald E, Isselbacher KJ, eds. Harrison’s principles of internal medicine. 14th ed. New York, NY: McGraw Hill, 1998: 1922–8.
9. Sarcoidosis 1985; 2:35–7.
B. Sarcoidosis in Eastern Europe.
10. Fraser RS, Müler NL, Colman N, Pare PD. Sarcoidosis. WB Saunders Comp. Diagnosis of diseases of the chest. Fourth Ed. Philadelphia. 1999:1533–83.
11. Am J Med 1996; 100:423–7.
< NM, Mannino DM. Sarcoidosisi mortality in the United States, 1979–1991: An analysis of multiple cause mortality data. https://doi.org/10.1016/S0002-9343(97)89518-6>
12. Sarcoidosis 1990; 7:43–9.
SK, Gupta S. Sarcoidosis in India: a review of 125 biopsy proven cases from eastern India.
13. Ann Klin Res 1970; 2:57–64.
M, Salo OP, Mustakallio KK. The prognosis of acute untreated sarcoidosis.
14. Am J Epidemiol 1986; 123: 840–5.
< CV, Henke G, Elvebeck LR et al. The epidemiology of sarcoidosis in Rochester, Minnesota: a population based study of incidence and survival. https://doi.org/10.1093/oxfordjournals.aje.a114313>
15. Am Rev Respir Dis 1984; 130:29–32.
G,Nou E, Osterman K, Schmekel B. Sarcoidosis: epidemiology and prognosis. A 15 year European study.
16. Ann NY Acad Sci 1976; 278:355–67.
< Y, Hiraga Y, Odaca M et al. A cooperative study of sarcoidosis in Asia and Africa: analytic epidemiology. https://doi.org/10.1111/j.1749-6632.1976.tb47046.x>
17. Eur J Respir Dis 1981; 62:231–8.
Ct, Heurich AE, Sumon AL, Lyons HA. Mortality in sarcoidosis. A changing pattern of the causes of death.
18. Br J Dis Chest 1987; 81:381–90.
< E,Poukkula A, Lilja M. Prognosis for sarcoidosis in a defined geographical area. https://doi.org/10.1016/0007-0971(87)90187-2>
19. Acta Pathol Japan 1993; 43:372–6.
K, Tachibana T, Takemura T et al. Pathological studies on sarcoidosis autopsy. I. Epidemiological features of 320 cases in Japan.
20. Sarcoidosis 1992; 9:105–18.
T. Symposium:Population differences in clinical futures and progression of sarcoidosis throughout the world.
21. Sarcoidosis 1989; 61:138–46.
M, Hosoda Y, Sasaki R, Aoki K. Epidemiological study on sarcoidosis in Japan. Recent trends in incidence and prevalance rates and changes in epidemiological features.
22. Sarcoidosis 1990; 7:1–8.
DG. The many faces of sarcoidosis. The Thome Villar memorial lecture.
23. Am J Med 1985; 78:61–7.
MR; Johnson RE. Course and prognosis of sarcoidosis in a nonreferral setting. Analysis of 86 patients observed for 10 years.
24. CHEST 2002; 121:32–5.
MR. Mortality of intrathoracic sarcoidosis in Referral versus Population- Based settings. Influence of stage, ethnicity and corticosteroid therapy.
25. Curr Opin Pulm Med 2000; 6(5):448–54.
< SK, Gupta D, Aggarwal AN. Sarcoidosis in developing countries. https://doi.org/10.1097/00063198-200009000-00011>
26. Scott Med J 1986; 31:72–8.
< RN. Pulmonary sarcoidosis after ten to twenty years. https://doi.org/10.1177/003693308603100203>
27. Sarcoidosis Vasc Diffuse Lung Dis 2002; 19(2):143–7.
R,Schilero GJ, Padilla ML, Teirstein AS. Sarcoidosis presenting in patients older than 50 years.
28. Am J Respir Crit Care 1995; 52:557–64.
< M, Tinelli C, Kolek V et al. The sarcoidosis map; ajoint survey of clinical and immunogenetic findings in two European countries. https://doi.org/10.1164/ajrccm.152.2.7633707>
29. Am Review Respir Dis 1961; 84(Suppl):116–9.
IM. Mortality from sarcoidosis in the United Studies.
30. Q J Med 1983; 208:525–33.
E; Walker AN, Geraint James D. Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients.
31. Am J Med 1985; 78:61–7.
< JM, Johnson RE. Course and prognosis of sarcoidosis in a nonreferral setting: analysis of 86 patients observed for years. https://doi.org/10.1016/0002-9343(85)90463-2>
32. Sarcoidosis Vask Diffuse Lung Dis 1996; 13:173–7.
JM, Johnson RE. Estimated incidence of clinically identified sarcoidosis in a Northwest United States population.
33. Am Rev Respir Dis 1967; 96:361–8.
D.Observations on the course and prognosis of sarcoidosis.
34. Dan Med Bul 1982; 29:27–32.
FK. Presentation of sarcoidosis and outcome of pulmonary changes.
35. BMJ 1961; 4:1165–72.
< JG. Prognosis of intrathoracic sarcoidosis in England: a review of 136 cases after 5 years of observation. https://doi.org/10.1136/bmj.2.5261.1165>
<PubMed>
36. Am J Med 1974; 57:847–52.
< LE, Geraint JDG, Neville E, et al. Course and prognosis of sarcoidosis around the world. https://doi.org/10.1016/0002-9343(74)90160-0>
37. Q J Med 1960; 29:539–58.
H,Hoyle C. The natural history of pulmonary sarcoidosis.
38. Am J Med 1960; 29: 84–93.
< M, Israel HL. Course and prognosis of sarcoidosis. https://doi.org/10.1016/0002-9343(60)90009-7>
39. Teirstein AS, Lesser M. Worldwide distribution and epidemiology of sarcoidosis. IN: James DG, editor. Sarcoidosis and other granulamatous diseases of the lung.New York: Marcel Decker, 1983. 101–34.
40. JAMA 1974; 66:386–8.
RC,Hackney R, Harden KA. Epidemiology of sarcoidosis: ethnic and geographic considerations.